Cited by 41Mitochondrial Function and PathologyCell death mechanisms and regulationIron Metabolism and Disorders

Iron alters cell survival in a mitochondria-dependent pathway in ovarian cancer cells

Open access
Bauckman, Kyle, Haller, Edward, Taran, Nicholas, Rockfield, Stephanie, Ruiz-Rivera, Abigail, Nanjundan, Meera·2015·Biochemical Journal

Abstract

The role of iron in the development of cancer remains unclear. We previously reported that iron reduces cell survival in a Ras/mitogen-activated protein kinase (MAPK)-dependent manner in ovarian cells; however, the underlying downstream pathway leading to reduced survival was unclear. Although levels of intracellular iron, ferritin/CD71 protein and reactive oxygen species did not correlate with iron-induced cell survival changes, we identified mitochondrial damage (via TEM) and reduced expression of outer mitochondrial membrane proteins (translocase of outer membrane: TOM20 and TOM70) in cell lines sensitive to iron. Interestingly, Ru360 (an inhibitor of the mitochondrial calcium uniporter) reversed mitochondrial changes and restored cell survival in HEY ovarian carcinoma cells treated with iron. Further, cells treated with Ru360 and iron also had reduced autophagic punctae with increased lysosomal numbers, implying cross-talk between these compartments. Mitochondrial changes were dependent on activation of the Ras/MAPK pathway since treatment with a MAPK inhibitor restored expression of TOM20/TOM70 proteins. Although glutathione antioxidant levels were reduced in HEY treated with iron, extracellular glutamate levels were unaltered. Strikingly, oxalomalate (inhibitor of aconitase, involved in glutamate production) reversed iron-induced responses in a similar manner to Ru360. Collectively, our results implicate iron in modulating cell survival in a mitochondria-dependent manner in ovarian cancer cells.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1042/bj20140878

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Surplus iron is needed during early steps of tumor development for enhanced survival and proliferation of transformed cells.

    “This surplus of iron is needed not only both during early steps of tumor development, e.g., enhanced survival [11] and proliferation of transformed cells [12], but also during late stages to promote the metastatic cascade.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bauckman, K., Haller, E., Taran, N., Rockfield, S., Ruiz-Rivera, A., & Nanjundan, M.
Affiliations
  • Moffitt Cancer Center (US)
  • University of South Florida (US)
  • Department of Cell Biology, Microbiology, and Molecular Biology, University of South Florida, Tampa, FL 33620, U.S.A.
Corresponding author
  • Bauckman, Kyle
  • Nanjundan, Meera
Venue
Biochemical Journal
Published
2015-02-20
Volume
466
Issue
2
Pages
401-413
ISSN
  • 0264-6021 (ISSN-L)
  • 1470-8728
OpenAlex
W2157853803
Cited by
41
References
56
Citations by year
2025: 2 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 8 · 2020: 4 · 2019: 4 · 2018: 6 · 2017: 6 · 2016: 1 · 2015: 1
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • Biochemical Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R21CA178468)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
Keywords
iron, ovarian cancer, cell survival, mitochondria, mitochondrial calcium uniporter, Ru360, Tom20, Tom70, mitochondrial outer membrane, RAS/MAPK pathway, autophagy, lysosomes, glutathione, aconitase, glutamate, oxidative stress
MeSH terms
Aconitate Hydratase, Quaternary Ammonium Compounds, Antineoplastic Agents, Autophagy, Calcium Channel Blockers, Carcinoma, Cell Line, Cell Survival, Enzyme Inhibitors, Female, Ferric Compounds, Glutathione, Humans, Lysosomes, Mitochondria, Neoplasm Proteins, Ovarian Neoplasms, Ovary, Calcium Channels, Reactive Oxygen Species, Oxidative Stress, MAP Kinase Signaling System, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review